About Genepoint Biological Technology
Genepoint Biological Technology is a company based in Shanghai (China) founded in 2015. Genepoint Biological Technology has raised $48.3 million across 4 funding rounds from investors including MGI Tech, New Hope Group and Zhongke Guosheng. Genepoint Biological Technology operates in a competitive market with competitors including Brooks Automation, Bridge to Life, Hemanext, Atelerix and Cellbox Solutions, among others.
- Headquarter Shanghai, China
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$48.3 M (USD)
in 4 rounds
-
Latest Funding Round
$29.54 M (USD), Series D
Jan 18, 2023
-
Investors
MGI Tech
& 8 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Genepoint Biological Technology
Genepoint Biological Technology has successfully raised a total of $48.3M across 4 strategic funding rounds. The most recent funding activity was a Series D round of $29.54 million completed in January 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Genepoint Biological Technology
Genepoint Biological Technology has secured backing from 9 investors, including venture fund and institutional investors. Prominent investors backing the company include MGI Tech, New Hope Group and Zhongke Guosheng.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
Provider of early stage venture capital focused on technology companies
|
Locked | Locked | Locked | |
|
Chinese startups are funded and incubated by Legend Star.
|
Locked | Locked | Locked |
Investor details for Genepoint Biological Technology
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Genepoint Biological Technology
Investment portfolio details for Genepoint Biological Technology
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Genepoint Biological Technology
Detailed financials for Genepoint Biological Technology
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Genepoint Biological Technology Comparisons
Peer comparison for Genepoint Biological Technology
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Genepoint Biological Technology
Genepoint Biological Technology operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Brooks Automation, Bridge to Life, Hemanext, Atelerix and Cellbox Solutions, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Vacuum robots for semiconductor wafer handling are developed.
|
|
| Locked | Locked | Locked |
Cold storage solutions for organ transplant preservation are provided.
|
|
| Locked | Locked | Locked |
Technologies for blood and product storage are developed.
|
|
| Locked | Locked | Locked |
Technology for cell storage and transportation is developed.
|
|
| Locked | Locked | Locked |
Portable devices for cell storage and transport are provided.
|
|
| Locked | Locked | Locked |
Thermal packaging solutions and cold chain monitoring services are provided.
|
Detailed competitors of Genepoint Biological Technology
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Genepoint Biological Technology
Complete news archive for Genepoint Biological Technology
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Genepoint Biological Technology
Genepoint Biological Technology was founded in 2015 and raised its 1st funding round 3 years after it was founded.
Genepoint Biological Technology is headquartered in Shanghai, China.
Ding Fubin is the current CEO of Genepoint Biological Technology.
Genepoint Biological Technology is a funded company, having raised a total of $48.3M across 4 funding rounds to date.
Genepoint Biological Technology was founded in 2015 and is based in Shanghai, China. Operations focus on the biotechnology sector, where a platform for cryostorage and long-term preservation is developed. Key products include a cryogenic cell storage automation system, a flexible robot for biobanking, a LIN vapor cryo-freezer, and a hoist for freezer handling. These solutions support biobanking and preservation needs in research and medical applications.
Genepoint Biological Technology's top competitors include Brooks Automation, Hemanext and Bridge to Life.
Genepoint Biological Technology has 9 investors. Key investors include MGI Tech, New Hope Group, Zhongke Guosheng, Huajin Capital, and Shanghai Guofang Private Equity Fund Management.